Filing Details
- Accession Number:
- 0001209191-23-040105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-28 20:31:53
- Reporting Period:
- 2023-06-26
- Accepted Time:
- 2023-06-28 20:31:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1863127 | Tyra Biosciences Inc. | TYRA | Pharmaceutical Preparations (2834) | 831476348 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1880946 | Daniel Bensen | C/O Tyra Biosciences, Inc. 2656 State Street Carlsbad CA 92008 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-06-26 | 17,232 | $0.61 | 545,213 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-06-26 | 10,862 | $16.49 | 534,351 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-06-26 | 6,370 | $17.24 | 527,981 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2023-06-27 | 16,028 | $0.61 | 544,009 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-06-27 | 7,893 | $16.73 | 536,116 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-06-27 | 8,135 | $17.09 | 527,981 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2023-06-28 | 13,524 | $0.61 | 541,505 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-06-28 | 13,524 | $16.91 | 527,981 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2023-06-26 | 17,232 | $0.00 | 17,232 | $0.61 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2023-06-27 | 16,028 | $0.00 | 16,028 | $0.61 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2023-06-28 | 13,524 | $0.00 | 13,524 | $0.61 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
211,830 | 2030-01-26 | No | 4 | M | Direct | |
195,802 | 2030-01-26 | No | 4 | M | Direct | |
182,278 | 2030-01-26 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.01 to $17.005. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.02 to $17.69. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.01 to $17.01. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.02 to $17.20. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.50 to $17.09. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.